4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-012359
Chief Technology Officer sold 20,000 shares at $10.94 ($218,800)
- Chief Technology Officer gave up 772 shares (to pay taxes)
- Chief Technology Officer acquired 1,981 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming Chief Technology Officer | 2023-02-21 | Option exercise | +1,981 | 7,946,825 | D | ||
| Yan Ming Chief Technology Officer | 2023-02-21 | Shares withheld for taxes | −772 | $10.97 | $8,469 | 7,946,053 | D |
| Yan Ming Chief Technology Officer | 2023-02-21 | Sale | −20,000 | $10.94 | $218,800 | 7,926,053 | D |
| Derivatives | |||||||
| Yan Ming Chief Technology Officer | 2023-02-21 | Option exercise · Restricted Stock Units | −1,981 | 23,123 | D | ||
| Open-market sales · 20,000 sh · avg $10.94 · $218,800 | |||||||
Loading xslF345X03/doc4.xml…